Curis Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
58,193.50
49,764.10
82,191.00
44,485.00
60,232.00
24,270
Total Accounts Receivable
1,477.20
1,961.00
2,106.00
2,459.00
3,073.00
2,864
Other Current Assets
443.80
446.20
1,204.40
1,257.00
989.00
827
Total Current Assets
60,114.50
52,171.30
85,501.50
48,201.00
64,294.00
27,961
Net Property, Plant & Equipment
445.70
407.70
277.70
413.00
366.00
267
Total Investments and Advances
10,893.20
941.40
152.60
153.00
153.00
153
Intangible Assets
8,982.00
8,982.00
8,982.00
8,982.00
8,982.00
8,982
Other Assets
155.50
111.20
51.30
3.00
3.00
2
Total Assets
80,590.80
62,613.60
94,965.10
57,752.00
73,798.00
37,365
ST Debt & Current Portion LT Debt
2,610.20
5,710.00
4,606.50
4,939.00
5,886.00
Accounts Payable
2,036.90
2,349.20
4,217.60
5,883.00
5,423.00
Other Current Liabilities
1,911.50
2,007.70
1,933.60
2,725.00
2,793.00
Total Current Liabilities
6,558.50
10,066.90
10,757.70
13,547.00
14,102.00
Long-Term Debt
27,945.20
22,589.10
19,558.00
14,921.00
35,669.00
Other Liabilities
913.50
174.00
139.00
18.00
34.00
Total Liabilities
35,417.20
32,829.90
30,454.70
28,486.00
49,805.00
Common Equity (Total)
45,173.60
29,783.60
64,510.50
29,266.00
23,993.00
Total Shareholders' Equity
45,173.60
29,783.60
64,510.50
29,266.00
23,993.00
Total Equity
45,173.60
29,783.60
64,510.50
29,266.00
23,993.00
Liabilities & Shareholders' Equity
80,590.80
62,613.60
94,965.10
57,752.00
73,798.00

About Curis

View Profile
Address
4 Maguire Road
Lexington Massachusetts 02421
United States
Employees -
Website http://www.curis.com
Updated 07/08/2019
Curis, Inc. is a biotechnology company, which is focused on the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes.